 Monika Headrick
Concepts (536)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 42 | 2023 | 855 | 5.620 |
Why?
| | Erythrocytes | 28 | 2024 | 590 | 5.170 |
Why?
| | Blood Proteins | 11 | 2020 | 238 | 3.920 |
Why?
| | Proteome | 20 | 2022 | 345 | 3.890 |
Why?
| | Blood Preservation | 16 | 2024 | 263 | 3.650 |
Why?
| | Erythrocyte Transfusion | 9 | 2023 | 187 | 2.940 |
Why?
| | Hemolysis | 12 | 2024 | 146 | 2.640 |
Why?
| | Fibrinolysis | 7 | 2022 | 160 | 2.080 |
Why?
| | Extracellular Matrix Proteins | 5 | 2021 | 128 | 1.900 |
Why?
| | Extracellular Matrix | 8 | 2023 | 439 | 1.770 |
Why?
| | Mass Spectrometry | 14 | 2019 | 661 | 1.560 |
Why?
| | Chromatography, Liquid | 7 | 2017 | 346 | 1.430 |
Why?
| | Blood Coagulation Disorders | 5 | 2023 | 196 | 1.370 |
Why?
| | Mesentery | 3 | 2014 | 53 | 1.350 |
Why?
| | Anemia, Sickle Cell | 4 | 2023 | 221 | 1.330 |
Why?
| | Wounds and Injuries | 6 | 2022 | 731 | 1.290 |
Why?
| | beta-Thalassemia | 4 | 2023 | 23 | 1.200 |
Why?
| | Tandem Mass Spectrometry | 7 | 2016 | 416 | 1.170 |
Why?
| | Lymph | 3 | 2018 | 40 | 1.110 |
Why?
| | Tissue Plasminogen Activator | 6 | 2023 | 228 | 1.110 |
Why?
| | Plasma | 4 | 2017 | 213 | 1.080 |
Why?
| | Blood Coagulation | 6 | 2023 | 221 | 1.030 |
Why?
| | Tissue Scaffolds | 2 | 2019 | 180 | 1.010 |
Why?
| | Extracellular Vesicles | 5 | 2023 | 82 | 0.980 |
Why?
| | Blood Platelets | 4 | 2015 | 350 | 0.980 |
Why?
| | Plateletpheresis | 2 | 2015 | 25 | 0.980 |
Why?
| | Survival of Motor Neuron 1 Protein | 2 | 2016 | 7 | 0.970 |
Why?
| | Lipopolysaccharides | 10 | 2022 | 832 | 0.920 |
Why?
| | Reticulocytes | 1 | 2023 | 17 | 0.910 |
Why?
| | Isoantibodies | 1 | 2023 | 52 | 0.880 |
Why?
| | Blood Donors | 5 | 2024 | 89 | 0.870 |
Why?
| | Oxidative Stress | 10 | 2022 | 1096 | 0.790 |
Why?
| | Metabolome | 4 | 2021 | 286 | 0.790 |
Why?
| | Arginine | 1 | 2022 | 241 | 0.770 |
Why?
| | Humans | 81 | 2024 | 115901 | 0.770 |
Why?
| | Animals | 38 | 2023 | 32122 | 0.740 |
Why?
| | Sex Characteristics | 3 | 2015 | 644 | 0.720 |
Why?
| | Shock, Hemorrhagic | 5 | 2023 | 193 | 0.720 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2017 | 313 | 0.690 |
Why?
| | Hypoxia | 7 | 2023 | 937 | 0.690 |
Why?
| | Acellular Dermis | 1 | 2019 | 12 | 0.690 |
Why?
| | Lipid Metabolism | 2 | 2017 | 449 | 0.690 |
Why?
| | Metabolomics | 7 | 2024 | 536 | 0.660 |
Why?
| | Thrombelastography | 7 | 2023 | 179 | 0.640 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 343 | 0.630 |
Why?
| | Coronavirus Infections | 2 | 2020 | 335 | 0.630 |
Why?
| | Complement System Proteins | 2 | 2021 | 288 | 0.630 |
Why?
| | Hemoglobins | 4 | 2022 | 313 | 0.620 |
Why?
| | Tissue Engineering | 3 | 2019 | 366 | 0.620 |
Why?
| | Mice | 19 | 2023 | 15073 | 0.610 |
Why?
| | Hydroxylamine | 1 | 2017 | 8 | 0.600 |
Why?
| | Hydrogels | 4 | 2023 | 581 | 0.590 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2017 | 82 | 0.590 |
Why?
| | Interleukin-6 | 2 | 2020 | 679 | 0.570 |
Why?
| | Mycophenolic Acid | 1 | 2017 | 81 | 0.560 |
Why?
| | Nucleotides | 1 | 2017 | 113 | 0.550 |
Why?
| | Pandemics | 3 | 2023 | 1333 | 0.540 |
Why?
| | Coiled Bodies | 1 | 2016 | 7 | 0.540 |
Why?
| | Campylobacter jejuni | 3 | 2011 | 11 | 0.540 |
Why?
| | Microtubule-Associated Proteins | 2 | 2021 | 176 | 0.520 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.510 |
Why?
| | Myocardium | 3 | 2022 | 929 | 0.510 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2020 | 13 | 0.510 |
Why?
| | Extinction, Biological | 1 | 2015 | 29 | 0.500 |
Why?
| | Oxidation-Reduction | 7 | 2021 | 933 | 0.490 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2016 | 141 | 0.490 |
Why?
| | Nanoparticles | 2 | 2022 | 318 | 0.460 |
Why?
| | Neutrophils | 4 | 2022 | 1170 | 0.460 |
Why?
| | Lymph Nodes | 2 | 2018 | 422 | 0.450 |
Why?
| | Proteolysis | 2 | 2017 | 145 | 0.440 |
Why?
| | Erythrocyte Deformability | 1 | 2022 | 12 | 0.430 |
Why?
| | Paxillin | 1 | 2022 | 10 | 0.430 |
Why?
| | Thrombophilia | 1 | 2023 | 67 | 0.430 |
Why?
| | Collagen | 1 | 2015 | 415 | 0.430 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 666 | 0.430 |
Why?
| | Repressor Proteins | 1 | 2016 | 369 | 0.430 |
Why?
| | Male | 28 | 2023 | 56127 | 0.420 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2012 | 37 | 0.420 |
Why?
| | Oxygen | 3 | 2022 | 839 | 0.420 |
Why?
| | Valosin Containing Protein | 1 | 2022 | 6 | 0.420 |
Why?
| | Biomarkers | 8 | 2022 | 3474 | 0.410 |
Why?
| | Cell Proliferation | 6 | 2022 | 2196 | 0.410 |
Why?
| | Superoxides | 2 | 2022 | 215 | 0.410 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 528 | 0.410 |
Why?
| | Glycolysis | 4 | 2022 | 222 | 0.410 |
Why?
| | O Antigens | 3 | 2006 | 8 | 0.410 |
Why?
| | Cytoplasmic Dyneins | 1 | 2021 | 7 | 0.400 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2022 | 21 | 0.400 |
Why?
| | Carnitine | 1 | 2022 | 61 | 0.400 |
Why?
| | Female | 27 | 2023 | 60081 | 0.400 |
Why?
| | Nervous System Malformations | 1 | 2022 | 34 | 0.390 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 794 | 0.390 |
Why?
| | Plesiomonas | 3 | 2006 | 3 | 0.380 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 138 | 0.380 |
Why?
| | Gangliosides | 1 | 2011 | 19 | 0.380 |
Why?
| | Endosomes | 1 | 2021 | 125 | 0.370 |
Why?
| | Breast Neoplasms | 3 | 2022 | 1870 | 0.360 |
Why?
| | Glioblastoma | 1 | 2022 | 251 | 0.350 |
Why?
| | Thrombosis | 1 | 2022 | 302 | 0.340 |
Why?
| | Biological Products | 1 | 2022 | 172 | 0.340 |
Why?
| | Proteins | 2 | 2023 | 922 | 0.340 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2019 | 43 | 0.340 |
Why?
| | Resuscitation | 3 | 2017 | 248 | 0.340 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 40 | 0.330 |
Why?
| | Androgen Antagonists | 1 | 2019 | 69 | 0.330 |
Why?
| | Molecular Sequence Data | 9 | 2015 | 2793 | 0.330 |
Why?
| | Adult | 18 | 2023 | 30817 | 0.330 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 376 | 0.330 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 400 | 0.330 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 84 | 0.320 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 302 | 0.320 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1138 | 0.310 |
Why?
| | Energy Metabolism | 3 | 2022 | 712 | 0.310 |
Why?
| | Cells, Cultured | 7 | 2021 | 3916 | 0.310 |
Why?
| | Middle Aged | 14 | 2023 | 27083 | 0.310 |
Why?
| | Androgens | 1 | 2019 | 165 | 0.310 |
Why?
| | Hematopoietic Stem Cells | 1 | 2021 | 356 | 0.300 |
Why?
| | Lymphokines | 1 | 2017 | 115 | 0.290 |
Why?
| | Ketones | 1 | 2017 | 44 | 0.290 |
Why?
| | Inflammation | 7 | 2023 | 2503 | 0.290 |
Why?
| | Transcriptome | 3 | 2022 | 742 | 0.290 |
Why?
| | Leukocyte Reduction Procedures | 2 | 2018 | 25 | 0.290 |
Why?
| | Cell Line, Tumor | 7 | 2022 | 2749 | 0.290 |
Why?
| | Asparagine | 2 | 2018 | 29 | 0.290 |
Why?
| | Chondrogenesis | 2 | 2020 | 79 | 0.280 |
Why?
| | alpha 1-Antitrypsin | 2 | 2022 | 110 | 0.280 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.280 |
Why?
| | Rats | 7 | 2023 | 5035 | 0.280 |
Why?
| | Hemorrhage | 4 | 2023 | 616 | 0.280 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2022 | 488 | 0.280 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 26 | 0.280 |
Why?
| | Aldehydes | 1 | 2017 | 146 | 0.280 |
Why?
| | Glycolipids | 1 | 2016 | 37 | 0.270 |
Why?
| | Time Factors | 6 | 2018 | 6186 | 0.270 |
Why?
| | Molecular Chaperones | 1 | 2017 | 157 | 0.270 |
Why?
| | Neutrophil Activation | 2 | 2018 | 93 | 0.270 |
Why?
| | Lung | 3 | 2015 | 3685 | 0.270 |
Why?
| | Injury Severity Score | 2 | 2018 | 460 | 0.270 |
Why?
| | Milk | 1 | 2016 | 124 | 0.260 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2017 | 484 | 0.250 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2019 | 638 | 0.250 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 144 | 0.250 |
Why?
| | Electrophoresis, Capillary | 3 | 2008 | 21 | 0.250 |
Why?
| | Brain Neoplasms | 1 | 2022 | 979 | 0.240 |
Why?
| | Glycoproteins | 1 | 2016 | 308 | 0.240 |
Why?
| | Protein Conformation | 1 | 2017 | 822 | 0.240 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2015 | 101 | 0.240 |
Why?
| | Cell Membrane | 2 | 2016 | 682 | 0.240 |
Why?
| | Ubiquitination | 2 | 2016 | 86 | 0.240 |
Why?
| | Bacteria | 2 | 2022 | 731 | 0.240 |
Why?
| | Interferons | 2 | 2022 | 152 | 0.230 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2000 | 0.230 |
Why?
| | Blood Group Antigens | 1 | 2023 | 14 | 0.230 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 10 | 0.230 |
Why?
| | Epitopes | 3 | 2008 | 438 | 0.230 |
Why?
| | Reactive Oxygen Species | 5 | 2022 | 552 | 0.230 |
Why?
| | Haemophilus influenzae | 2 | 2008 | 50 | 0.230 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2022 | 274 | 0.230 |
Why?
| | Glucose | 3 | 2018 | 904 | 0.220 |
Why?
| | Birth Injuries | 1 | 2023 | 11 | 0.220 |
Why?
| | Swine | 3 | 2023 | 706 | 0.220 |
Why?
| | Proteasome Endopeptidase Complex | 3 | 2022 | 136 | 0.220 |
Why?
| | Hypocalcemia | 1 | 2023 | 31 | 0.220 |
Why?
| | Sphingosine | 1 | 2023 | 32 | 0.220 |
Why?
| | Acute-Phase Proteins | 2 | 2014 | 64 | 0.220 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 40 | 0.220 |
Why?
| | Solubility | 2 | 2017 | 227 | 0.220 |
Why?
| | DNA Modification Methylases | 1 | 2022 | 14 | 0.210 |
Why?
| | Carbohydrate Sequence | 7 | 2008 | 23 | 0.210 |
Why?
| | Serpins | 1 | 2022 | 27 | 0.210 |
Why?
| | Platelet Transfusion | 1 | 2023 | 63 | 0.210 |
Why?
| | Arginase | 1 | 2022 | 27 | 0.210 |
Why?
| | Lysophospholipids | 1 | 2023 | 65 | 0.210 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2022 | 37 | 0.210 |
Why?
| | Signal Transduction | 6 | 2022 | 4526 | 0.210 |
Why?
| | Erythroblasts | 1 | 2022 | 12 | 0.210 |
Why?
| | Citrulline | 1 | 2022 | 39 | 0.210 |
Why?
| | Protein Transport | 2 | 2021 | 400 | 0.210 |
Why?
| | Blood Banks | 2 | 2021 | 40 | 0.210 |
Why?
| | Rejuvenation | 2 | 2021 | 14 | 0.210 |
Why?
| | Case-Control Studies | 5 | 2022 | 3056 | 0.210 |
Why?
| | Macrophages | 4 | 2023 | 1281 | 0.210 |
Why?
| | beta-Globins | 1 | 2022 | 15 | 0.200 |
Why?
| | Endothelial Cells | 3 | 2023 | 694 | 0.200 |
Why?
| | Fibrinolysin | 1 | 2022 | 15 | 0.200 |
Why?
| | Isoaspartic Acid | 1 | 2021 | 3 | 0.200 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2021 | 5 | 0.200 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 22 | 0.200 |
Why?
| | Blood | 1 | 2022 | 97 | 0.200 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2015 | 337 | 0.200 |
Why?
| | Methods | 2 | 2018 | 59 | 0.190 |
Why?
| | Cell Cycle Proteins | 3 | 2022 | 555 | 0.190 |
Why?
| | Receptors, Glucocorticoid | 1 | 2022 | 143 | 0.190 |
Why?
| | Hypertension, Pulmonary | 2 | 2022 | 1752 | 0.190 |
Why?
| | Virulence Factors | 1 | 2022 | 139 | 0.190 |
Why?
| | Saccharomyces cerevisiae | 2 | 2015 | 482 | 0.190 |
Why?
| | Erythrocyte Membrane | 1 | 2021 | 50 | 0.190 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.190 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 27 | 0.190 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 249 | 0.180 |
Why?
| | Betacoronavirus | 2 | 2020 | 253 | 0.180 |
Why?
| | Aging | 3 | 2021 | 1641 | 0.180 |
Why?
| | Thrombin | 3 | 2023 | 141 | 0.180 |
Why?
| | Databases, Genetic | 1 | 2021 | 200 | 0.180 |
Why?
| | Lipid A | 2 | 2008 | 27 | 0.180 |
Why?
| | Membrane Lipids | 1 | 2020 | 87 | 0.180 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4767 | 0.180 |
Why?
| | Spermatogenesis | 1 | 2020 | 52 | 0.180 |
Why?
| | Altitude | 1 | 2023 | 410 | 0.180 |
Why?
| | Antibodies, Bacterial | 2 | 2008 | 119 | 0.180 |
Why?
| | Cell Line | 5 | 2018 | 2655 | 0.170 |
Why?
| | Protein Stability | 2 | 2017 | 162 | 0.170 |
Why?
| | Parabiosis | 1 | 2019 | 12 | 0.170 |
Why?
| | Oligosaccharides | 3 | 2006 | 46 | 0.170 |
Why?
| | Dyneins | 1 | 2019 | 30 | 0.170 |
Why?
| | Nitric Oxide | 2 | 2022 | 834 | 0.170 |
Why?
| | Semen Analysis | 2 | 2020 | 10 | 0.170 |
Why?
| | Adenosine Triphosphatases | 2 | 2022 | 156 | 0.170 |
Why?
| | Fertility | 1 | 2020 | 131 | 0.160 |
Why?
| | Mitochondria | 2 | 2022 | 753 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 3 | 2022 | 168 | 0.160 |
Why?
| | Mice, Knockout | 2 | 2023 | 2607 | 0.160 |
Why?
| | Infertility, Male | 2 | 2020 | 60 | 0.160 |
Why?
| | Aspartic Acid | 1 | 2018 | 79 | 0.160 |
Why?
| | Proteus penneri | 1 | 2008 | 1 | 0.160 |
Why?
| | Spermatozoa | 2 | 2020 | 84 | 0.160 |
Why?
| | Myocytes, Cardiac | 1 | 2022 | 456 | 0.160 |
Why?
| | Blood Transfusion | 3 | 2022 | 277 | 0.150 |
Why?
| | Basophils | 1 | 2018 | 64 | 0.150 |
Why?
| | Sodium Chloride | 2 | 2015 | 137 | 0.150 |
Why?
| | Omalizumab | 1 | 2018 | 46 | 0.150 |
Why?
| | Acetylation | 4 | 2019 | 212 | 0.150 |
Why?
| | Anti-Allergic Agents | 1 | 2018 | 41 | 0.150 |
Why?
| | Protons | 2 | 2007 | 84 | 0.150 |
Why?
| | Hypoxanthine | 1 | 2017 | 10 | 0.150 |
Why?
| | Urticaria | 1 | 2018 | 51 | 0.150 |
Why?
| | Trastuzumab | 2 | 2022 | 89 | 0.150 |
Why?
| | Fibrinolytic Agents | 2 | 2022 | 233 | 0.150 |
Why?
| | Microtubules | 1 | 2019 | 238 | 0.140 |
Why?
| | Freeze Drying | 1 | 2017 | 75 | 0.140 |
Why?
| | Fibroblasts | 1 | 2021 | 838 | 0.140 |
Why?
| | Immune Sera | 2 | 2004 | 80 | 0.140 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.140 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 83 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2018 | 513 | 0.140 |
Why?
| | Preoperative Period | 1 | 2017 | 103 | 0.140 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.140 |
Why?
| | Purines | 1 | 2017 | 159 | 0.140 |
Why?
| | DNA | 2 | 2022 | 1358 | 0.140 |
Why?
| | Isotope Labeling | 1 | 2017 | 76 | 0.140 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1548 | 0.140 |
Why?
| | Epithelial Cells | 2 | 2016 | 965 | 0.140 |
Why?
| | Pancreas | 1 | 2018 | 280 | 0.140 |
Why?
| | Healthy Volunteers | 1 | 2017 | 191 | 0.140 |
Why?
| | Mammals | 3 | 2022 | 251 | 0.140 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 53 | 0.140 |
Why?
| | Apoptosis | 3 | 2022 | 2377 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2262 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.130 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2016 | 17 | 0.130 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 137 | 0.130 |
Why?
| | Workflow | 1 | 2017 | 136 | 0.130 |
Why?
| | Receptor, PAR-2 | 1 | 2015 | 8 | 0.130 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2015 | 30 | 0.130 |
Why?
| | Myocardial Infarction | 1 | 2022 | 931 | 0.130 |
Why?
| | Bison | 1 | 2015 | 6 | 0.130 |
Why?
| | Plasminogen | 1 | 2015 | 32 | 0.130 |
Why?
| | Chemical Fractionation | 1 | 2015 | 28 | 0.130 |
Why?
| | Bacterial Proteins | 4 | 2022 | 738 | 0.130 |
Why?
| | Gelsolin | 1 | 2014 | 9 | 0.120 |
Why?
| | Hafnia alvei | 1 | 2004 | 1 | 0.120 |
Why?
| | Serine Proteases | 1 | 2014 | 14 | 0.120 |
Why?
| | Microcirculation | 1 | 2015 | 138 | 0.120 |
Why?
| | Glycosylation | 1 | 2015 | 133 | 0.120 |
Why?
| | Kallikreins | 1 | 2014 | 31 | 0.120 |
Why?
| | Glutamine | 1 | 2015 | 90 | 0.120 |
Why?
| | Rats, Inbred F344 | 1 | 2015 | 245 | 0.120 |
Why?
| | Aquaporin 4 | 1 | 2015 | 86 | 0.120 |
Why?
| | Blood Component Transfusion | 1 | 2015 | 76 | 0.120 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2007 | 167 | 0.120 |
Why?
| | Muscle, Skeletal | 2 | 2023 | 1459 | 0.120 |
Why?
| | Skull | 1 | 2015 | 118 | 0.120 |
Why?
| | Complex Mixtures | 1 | 2014 | 12 | 0.120 |
Why?
| | Prognosis | 2 | 2022 | 3342 | 0.120 |
Why?
| | Organ Size | 1 | 2015 | 435 | 0.120 |
Why?
| | Peptide Hydrolases | 1 | 2014 | 109 | 0.120 |
Why?
| | Neural Stem Cells | 1 | 2015 | 114 | 0.110 |
Why?
| | Homeostasis | 2 | 2022 | 576 | 0.110 |
Why?
| | Pilot Projects | 1 | 2018 | 1374 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 123 | 0.110 |
Why?
| | Glycoconjugates | 1 | 2003 | 7 | 0.110 |
Why?
| | Blotting, Western | 2 | 2011 | 1153 | 0.110 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 114 | 0.110 |
Why?
| | Tetanus Toxoid | 1 | 2003 | 37 | 0.110 |
Why?
| | Stem Cell Niche | 1 | 2013 | 43 | 0.110 |
Why?
| | Cluster Analysis | 1 | 2014 | 466 | 0.110 |
Why?
| | Thromboplastin | 1 | 2023 | 71 | 0.110 |
Why?
| | Survival of Motor Neuron 2 Protein | 1 | 2012 | 3 | 0.110 |
Why?
| | Central Nervous System | 1 | 2015 | 239 | 0.110 |
Why?
| | Young Adult | 4 | 2021 | 10517 | 0.110 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2022 | 15 | 0.110 |
Why?
| | Cumulus Cells | 1 | 2012 | 6 | 0.110 |
Why?
| | Pyruvates | 1 | 2022 | 20 | 0.110 |
Why?
| | Inosine | 1 | 2022 | 11 | 0.110 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2012 | 15 | 0.110 |
Why?
| | Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 3 | 0.110 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 448 | 0.110 |
Why?
| | Lymphoid Tissue | 1 | 2022 | 63 | 0.100 |
Why?
| | Leukocyte Count | 1 | 2013 | 295 | 0.100 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 433 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 177 | 0.100 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2022 | 4 | 0.100 |
Why?
| | Endotoxins | 1 | 2003 | 208 | 0.100 |
Why?
| | Maternal Age | 1 | 2012 | 117 | 0.100 |
Why?
| | Catalase | 1 | 2022 | 118 | 0.100 |
Why?
| | Oxygen Consumption | 1 | 2014 | 572 | 0.100 |
Why?
| | Acute Lung Injury | 2 | 2015 | 302 | 0.100 |
Why?
| | Ubiquitin | 1 | 2022 | 65 | 0.100 |
Why?
| | RNA-Binding Proteins | 1 | 2015 | 365 | 0.100 |
Why?
| | Quality Control | 1 | 2022 | 152 | 0.100 |
Why?
| | Leukocytes | 1 | 2013 | 284 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 304 | 0.100 |
Why?
| | Phosphates | 1 | 2022 | 160 | 0.100 |
Why?
| | beta 2-Microglobulin | 1 | 2011 | 45 | 0.100 |
Why?
| | Histones | 2 | 2022 | 539 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2023 | 3583 | 0.100 |
Why?
| | Datasets as Topic | 2 | 2022 | 100 | 0.100 |
Why?
| | Transglutaminases | 1 | 2022 | 144 | 0.100 |
Why?
| | Galactosyltransferases | 1 | 2011 | 11 | 0.100 |
Why?
| | Sialyltransferases | 1 | 2011 | 13 | 0.100 |
Why?
| | Transfusion Reaction | 1 | 2011 | 66 | 0.090 |
Why?
| | HeLa Cells | 1 | 2012 | 568 | 0.090 |
Why?
| | Lipids | 2 | 2023 | 589 | 0.090 |
Why?
| | Mice, SCID | 1 | 2021 | 321 | 0.090 |
Why?
| | Linoleic Acid | 1 | 2021 | 38 | 0.090 |
Why?
| | Adenosine | 1 | 2022 | 204 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2015 | 782 | 0.090 |
Why?
| | Cell Self Renewal | 1 | 2021 | 50 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2006 | 139 | 0.090 |
Why?
| | HEK293 Cells | 1 | 2012 | 604 | 0.090 |
Why?
| | Astrocytes | 1 | 2022 | 165 | 0.090 |
Why?
| | Risk Factors | 1 | 2023 | 8714 | 0.090 |
Why?
| | Rabbits | 3 | 2014 | 755 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 796 | 0.090 |
Why?
| | Substrate Specificity | 1 | 2011 | 356 | 0.090 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 721 | 0.090 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 562 | 0.090 |
Why?
| | Phenotype | 1 | 2017 | 2859 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2015 | 770 | 0.090 |
Why?
| | Multiple Myeloma | 1 | 2021 | 93 | 0.090 |
Why?
| | DNA Damage | 1 | 2022 | 356 | 0.090 |
Why?
| | Phenylthiohydantoin | 1 | 2019 | 40 | 0.090 |
Why?
| | Peptides | 1 | 2015 | 862 | 0.080 |
Why?
| | Bordetella pertussis | 1 | 2009 | 2 | 0.080 |
Why?
| | Models, Molecular | 2 | 2020 | 1391 | 0.080 |
Why?
| | Escherichia coli | 1 | 2003 | 730 | 0.080 |
Why?
| | Glucosamine | 1 | 2009 | 12 | 0.080 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 223 | 0.080 |
Why?
| | Histone Acetyltransferases | 1 | 2019 | 50 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4446 | 0.080 |
Why?
| | Nitriles | 1 | 2019 | 152 | 0.080 |
Why?
| | Benzamides | 1 | 2019 | 169 | 0.080 |
Why?
| | Miller Fisher Syndrome | 1 | 2008 | 2 | 0.080 |
Why?
| | Membrane Glycoproteins | 1 | 2011 | 429 | 0.080 |
Why?
| | Pregnancy | 3 | 2023 | 5555 | 0.080 |
Why?
| | Guillain-Barre Syndrome | 1 | 2008 | 21 | 0.080 |
Why?
| | Multigene Family | 1 | 2009 | 196 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1319 | 0.080 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2007 | 9 | 0.080 |
Why?
| | Critical Illness | 1 | 2013 | 646 | 0.080 |
Why?
| | Membrane Proteins | 2 | 2020 | 1033 | 0.070 |
Why?
| | Protein Binding | 2 | 2017 | 1919 | 0.070 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 45 | 0.070 |
Why?
| | Obesity | 1 | 2020 | 2530 | 0.070 |
Why?
| | Cell Adhesion | 2 | 2020 | 433 | 0.070 |
Why?
| | Hydrolysis | 1 | 2017 | 178 | 0.070 |
Why?
| | Molecular Weight | 1 | 2017 | 335 | 0.070 |
Why?
| | Aged | 4 | 2021 | 19299 | 0.070 |
Why?
| | Protein Aggregates | 1 | 2017 | 66 | 0.070 |
Why?
| | Glycine | 1 | 2007 | 156 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2011 | 703 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2015 | 1058 | 0.070 |
Why?
| | Butyrophilins | 1 | 2016 | 5 | 0.070 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 136 | 0.070 |
Why?
| | Lipid Droplets | 1 | 2016 | 21 | 0.070 |
Why?
| | Cross Reactions | 2 | 2008 | 116 | 0.070 |
Why?
| | Prospective Studies | 1 | 2017 | 6267 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2014 | 2814 | 0.070 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 60 | 0.070 |
Why?
| | Cytoplasm | 1 | 2016 | 255 | 0.070 |
Why?
| | Lactation | 1 | 2016 | 149 | 0.060 |
Why?
| | Methylation | 2 | 2018 | 206 | 0.060 |
Why?
| | Monocytes | 2 | 2023 | 504 | 0.060 |
Why?
| | Chromosome Segregation | 2 | 2015 | 36 | 0.060 |
Why?
| | Models, Chemical | 2 | 2006 | 264 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 194 | 0.060 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2023 | 27 | 0.060 |
Why?
| | Brain | 1 | 2015 | 2382 | 0.060 |
Why?
| | Kynurenine | 1 | 2024 | 80 | 0.060 |
Why?
| | Pelvic Floor | 1 | 2023 | 24 | 0.060 |
Why?
| | Cohort Studies | 1 | 2023 | 4961 | 0.060 |
Why?
| | Parturition | 1 | 2023 | 56 | 0.050 |
Why?
| | Molecular Structure | 2 | 2009 | 447 | 0.050 |
Why?
| | Angiopoietins | 1 | 2022 | 13 | 0.050 |
Why?
| | Thymidine | 1 | 2022 | 58 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 68 | 0.050 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 35 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 338 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 33 | 0.050 |
Why?
| | alpha-Globins | 1 | 2022 | 11 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 67 | 0.050 |
Why?
| | Mutation | 1 | 2022 | 3370 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2022 | 220 | 0.050 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 79 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 46 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 243 | 0.050 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 215 | 0.050 |
Why?
| | Chromatin | 2 | 2015 | 427 | 0.050 |
Why?
| | Membrane Microdomains | 1 | 2021 | 32 | 0.050 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 26 | 0.050 |
Why?
| | Adolescent | 2 | 2020 | 17956 | 0.050 |
Why?
| | Least-Squares Analysis | 1 | 2021 | 73 | 0.050 |
Why?
| | Fibrosis | 1 | 2023 | 455 | 0.050 |
Why?
| | Access to Information | 1 | 2021 | 50 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 141 | 0.050 |
Why?
| | Bacteriophage lambda | 1 | 2021 | 81 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 503 | 0.050 |
Why?
| | Phosphorylation | 2 | 2015 | 1561 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 632 | 0.050 |
Why?
| | Fatty Acids | 1 | 2023 | 385 | 0.050 |
Why?
| | Sulfhydryl Compounds | 1 | 2022 | 178 | 0.050 |
Why?
| | Data Mining | 1 | 2021 | 98 | 0.050 |
Why?
| | Heterozygote | 1 | 2021 | 254 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2020 | 1706 | 0.040 |
Why?
| | Sperm Count | 1 | 2020 | 16 | 0.040 |
Why?
| | Sperm Motility | 1 | 2020 | 26 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 175 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 157 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 445 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2021 | 302 | 0.040 |
Why?
| | Tissue Survival | 1 | 2018 | 13 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 447 | 0.040 |
Why?
| | Cell Communication | 1 | 2020 | 281 | 0.040 |
Why?
| | Pepsin A | 1 | 2018 | 18 | 0.040 |
Why?
| | Blood Buffy Coat | 1 | 2018 | 5 | 0.040 |
Why?
| | NF-kappa B | 1 | 2022 | 639 | 0.040 |
Why?
| | Sulfates | 1 | 2018 | 45 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 498 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 80 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 380 | 0.040 |
Why?
| | Fluorescence | 1 | 2018 | 153 | 0.040 |
Why?
| | Filtration | 1 | 2018 | 61 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 343 | 0.040 |
Why?
| | Bacteriological Techniques | 1 | 2018 | 64 | 0.040 |
Why?
| | Solutions | 1 | 2018 | 150 | 0.040 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.040 |
Why?
| | Calcium | 1 | 2023 | 1102 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 477 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.040 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1301 | 0.040 |
Why?
| | Bronchioles | 1 | 2016 | 22 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 553 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2424 | 0.030 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2006 | 87 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 84 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1476 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 543 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 261 | 0.030 |
Why?
| | Amides | 1 | 2006 | 89 | 0.030 |
Why?
| | Chromatids | 1 | 2015 | 8 | 0.030 |
Why?
| | HMGA2 Protein | 1 | 2015 | 8 | 0.030 |
Why?
| | Bromodeoxyuridine | 1 | 2015 | 74 | 0.030 |
Why?
| | Chromosomes | 1 | 2015 | 85 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 639 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2015 | 38 | 0.030 |
Why?
| | Electroporation | 1 | 2015 | 32 | 0.030 |
Why?
| | Immunoglobulin Light Chains | 1 | 2015 | 34 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 212 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 438 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 2004 | 15 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 154 | 0.030 |
Why?
| | Tranexamic Acid | 1 | 2015 | 40 | 0.030 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 72 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 155 | 0.030 |
Why?
| | Serologic Tests | 1 | 2004 | 51 | 0.030 |
Why?
| | Seminal Plasma Proteins | 1 | 2014 | 10 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 866 | 0.030 |
Why?
| | Embryo Implantation | 1 | 2014 | 23 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 527 | 0.030 |
Why?
| | Chromosomal Instability | 1 | 2014 | 19 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 319 | 0.030 |
Why?
| | Fetal Stem Cells | 1 | 2013 | 7 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2014 | 71 | 0.030 |
Why?
| | DNA Repair | 1 | 2015 | 192 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1647 | 0.030 |
Why?
| | Embryonic Development | 1 | 2014 | 115 | 0.030 |
Why?
| | Synovial Membrane | 1 | 2013 | 74 | 0.030 |
Why?
| | Species Specificity | 1 | 2004 | 555 | 0.030 |
Why?
| | Amino Acids | 1 | 2017 | 455 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1044 | 0.030 |
Why?
| | Microscopy, Atomic Force | 1 | 2013 | 116 | 0.030 |
Why?
| | Cell Count | 1 | 2013 | 304 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 238 | 0.030 |
Why?
| | Oocyte Donation | 1 | 2012 | 4 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 228 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 399 | 0.030 |
Why?
| | Immunoblotting | 1 | 2003 | 283 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 868 | 0.030 |
Why?
| | Body Mass Index | 1 | 2020 | 1982 | 0.030 |
Why?
| | Chronic Disease | 1 | 2018 | 1602 | 0.030 |
Why?
| | Silver Staining | 1 | 2002 | 17 | 0.030 |
Why?
| | Disaccharides | 1 | 2002 | 16 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1761 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2013 | 147 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1143 | 0.020 |
Why?
| | Cell Cycle | 1 | 2014 | 546 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 346 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 970 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1149 | 0.020 |
Why?
| | Antibodies | 1 | 2002 | 374 | 0.020 |
Why?
| | Gene Order | 1 | 2009 | 27 | 0.020 |
Why?
| | Glycosyltransferases | 1 | 2009 | 13 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 60 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2009 | 99 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1843 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2008 | 14 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2008 | 24 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2009 | 156 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2008 | 21 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 1857 | 0.020 |
Why?
| | Microwaves | 1 | 2008 | 32 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2008 | 308 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 28 | 0.020 |
Why?
| | Child | 1 | 2023 | 18557 | 0.010 |
Why?
|
|
Headrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|